JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|
Assets | ||||
Current assets | ||||
Inventory | -13.87%21.72M | -0.06%25.22M | 144.49%25.23M | --10.32M |
Accounts receivable | -26.17%77.47M | -45.78%104.93M | 45.86%193.51M | --132.67M |
Cash and equivalents | -45.74%716.34M | 52.07%1.32B | 395.98%868.09M | --175.03M |
Special items of current assets | ---- | --132.14M | ---- | ---- |
Total current assets | -48.73%817.08M | 41.47%1.59B | 239.66%1.13B | --331.67M |
Non-current assets | ||||
Property, plant and equipment | 18.19%1.18B | 0.05%999.46M | 202.08%998.97M | --330.69M |
Advance payment | -11.69%154.19M | 74.26%174.6M | 347.47%100.19M | --22.39M |
Associated company interest | 17.65%6.42M | -74.10%5.46M | 1,024.93%21.07M | --1.87M |
Intangible assets | 615.18%801K | 5,500.00%112K | -50.00%2K | --4K |
Total non-current assets | 13.82%1.34B | 5.30%1.18B | 215.59%1.12B | --354.96M |
Total assets | -22.13%2.16B | 23.44%2.77B | 227.22%2.25B | --686.64M |
Liabilities | ||||
Current liabilities | ||||
Accounts payable | -24.65%164.14M | -10.62%217.84M | 48.97%243.72M | --163.6M |
Tax payable | -0.37%3.74M | -55.60%3.75M | 2,636.25%8.46M | --309K |
Bank loans and overdrafts | ---- | ---- | 82.76%33.23M | --18.19M |
Financial lease liabilities-current liabilities | -47.31%84.67M | 51.57%160.68M | 506.99%106.01M | --17.47M |
Total current liabilities | -33.95%255.65M | -2.36%387.06M | 94.46%396.43M | --203.86M |
Net current assets | -53.47%561.43M | 65.27%1.21B | 471.26%730.14M | --127.81M |
Total assets less current liabilities | -20.21%1.9B | 28.96%2.39B | 283.28%1.85B | --482.78M |
Non-current liabilities | ||||
Long-term bank loan | ---- | ---- | 78.84%158.55M | --88.66M |
Financial lease liabilities-non-current liabilities | -41.86%132.54M | -6.63%227.96M | 1,662.85%244.16M | --13.85M |
Deferred tax liability | ---- | --7.37M | ---- | ---- |
Total non-current liabilities | -43.68%132.54M | -41.56%235.33M | 292.86%402.71M | --102.51M |
Total liabilities | -37.63%388.18M | -22.12%622.4M | 160.84%799.14M | --306.37M |
Total assets less total liabilities | -17.64%1.77B | 48.58%2.15B | 280.70%1.45B | --380.27M |
Total equity and non-current liabilities | -20.21%1.9B | 28.96%2.39B | 283.28%1.85B | --482.78M |
Equity | ||||
Share capital | 0.00%140M | 0.00%140M | 100.00%140M | --70M |
Reserve | -18.86%1.63B | 53.82%2.01B | 321.89%1.31B | --309.81M |
Shareholders' Equity | -17.63%1.77B | 48.61%2.15B | 281.00%1.45B | --379.81M |
Non-controlling interest | -64.50%164K | -21.69%462K | 29.67%590K | --455K |
Total equity | -17.64%1.77B | 48.58%2.15B | 280.70%1.45B | --380.27M |
Total equity and total liabilities | -22.13%2.16B | 23.44%2.77B | 227.22%2.25B | --686.64M |
Currency Unit | USD | USD | USD | USD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | KPMG | KPMG | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.